Point72 Asset Management’s 2seventy bio TSVT Stock Holding History
Bought
Maintained
Sold
Other funds holding TSVT
BCM
NM
BBA
CC
Point72 Asset Management's TSVT Position: Q1 2025 in Review
Point72 Asset Management sold out of 2seventy bio (TSVT) in Q1 2025, closing a stake of 310,637 shares — an estimated $913K sold.
Point72 Asset Management first reported a position in TSVT in Q4 2021 and held it in 11 quarters. The position peaked at $15M in Q4 2021. 139 funds tracked by Wall St. Rank hold TSVT as of Q1 2025.
- Point72 Asset Management reported no remaining 2seventy bio position as of Q1 2025 after selling out during the quarter.
- Point72 Asset Management sold 310,637 2seventy bio shares in Q1 2025, an estimated $913K.
- Point72 Asset Management first reported a position in 2seventy bio in Q4 2021 and held it in 11 quarters.
- Point72 Asset Management's 2seventy bio position peaked at $15M in Q4 2021.
- 139 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2025.
Based on Point72 Asset Management's 13F filing for Q1 2025, filed 15 May 2025.